Table 3. Long ncRNA expression in the heart.
Long ncRNA | Cardiac function | Disease association | Expression in disease (↑/↓) | Methods of identification | Mechanism of regulation | Splice variants | |
---|---|---|---|---|---|---|---|
ANRIL | Regulation of INK4/ARF locus, genes involved in nuclear and chromatin architecture56 | Cardiac hypertrophy, Atherosclerosis | ↑ | RNA-ChIP, RACE-PCR, circRNA assays | Chromatin interaction | Reported | |
cTnI-AS | Regulation of cTnI mRNA72 | Unknown | Unknown | RACE | RNA duplex formation | None reported | |
NPPA-AS1 | Regulation of NPPA mRNA68 | Unknown | Unknown | RACE | RNA duplex formation | Reported | |
AS-UCN | Regulation of sense transcription/translation124 | Unknown | Unknown | RNase Protection Assay | Overlapping sense transcription | None reported | |
MIAT or Gomafu | Splicing, Retinal cell fate specification125 | Myocardial Infarction | ↑ | Northern blot, RACE | Chromatin interaction / Nanog TF binding | Reported | |
Fendrr | Cardiac mesoderm formation17 | Unknown | Unknown | RACE, RNA-ChIP, ISH | Chromatin interaction | None reported | |
MHM | Cardiomyocyte Proliferation126 | Cardiac hypertrophy, arrhythmia | Unknown | Northern blot, In Situ hybridization |
Chromatin interaction | Reported | |
H19 | Imprinting and Igf2 regulation65 | Hypertrophy & Heart failure | ↑ | RNA-ChIP, Strand-specific PCR | Chromatin interaction | Reported | |
91H (AS-H19) | Regulation of Igf2127 | Unknown | Unknown | Strand-specific PCR | Unknown | None reported | |
Kcnq1ot1 | Embryonic heart formation, Regulation of Cdkn1c, KvLQT1 genes91 | Unknown | Unknown | RACE, FISH, RNA-ChIP | Chromatin interaction | Reported | |
FMR1-AS1 or FMR4 | Cell proliferation128 | Proposed | Unknown | RACE, Northern blot | Chromatin interaction proposed | Reported | |
Air | Embryonic heart formation, Imprinting of Igf2r in adult hearts129 | Unknown | Unknown | RNA-ChIP, FISH |
Chromatin interaction | Reported | |
MLC-ALC-1 antisense | Regulation of MLC-1 mRNA130 | ToF, HOCM | ↑ | Strand-specific PCR | Unknown | None reported | |
AS-TGFβ3 | Hear chamber formation131 | Unknown | Unknown | RNase protection assay | RISC-mediated silencing proposed | None reported | |
sONE (AS-eNOS) |
eNOS synthesis132 | Unknown | Unknown | Strand-specific PCR, In Situ hybridization | Unknown | None reported | |
SRA | Myogenesis, SRA proteins synthesis133 | DCM | ↓ | Strand-specific PCR, Splice variant assays, RNA-ChIP | Chromatin interaction | Reported | |
AS β-MHC | β-MHC gene transcription61 | Cardiac hypertrophy | ↓ | Strand-specific PCR | Chromatin interaction | None reported | |
Braveheart | Cardiovascular lineage commitment16 | Unknown | Unknown | RACE, native RNA-IP | Chromatin interaction | Reported |
ANRIL, Antisense non-coding RNA in the INK4 locus; cTnI, Cardiac troponin I; NPPA-AS1, natriuretic peptide precursor A-antisense transcript 1; AS-UCN, Urocortin antisense; MIAT, Myocardial Infarction associated transcript; MHM, Male HyperMethylated; MLC-ALC-1, myosin light chain-atrial light chain-1;AS-TGFβ3, Transforming growth factor β-3 antisense RNA; SRA, steroid receptor RNA activator; ToF, tetrology of fallot; HOCM, Hypertrophic obstructive cardiomyopathy; DCM, dilated cardiomyopathy. RACE, Rapid amplification of cDNA ends; FISH, Fluorescent In Situ Hybridization.